<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>LA041989-0130</title>
	</head>
	<body>
		<main>
			<p><P> April 19, 1989, Wednesday, Southland Edition  </P> <P> MEDCO RESEARCH EXTENDS RESEARCH  </P> <P> Medco Research Inc. of Los Angeles secured from the University of Virginia  Alumni Patents Foundation an extension of its exclusive right to research,  develop and market Adenocard for $200,000, according to a Securities and  Exchange Commission filing.  </P> <P> Under the agreement, Medco has until March, 1992, to obtain Federal Drug  Administration approval for Adenocard, an injectable acute treatment for  supraventricular tachycardia.  </P> <P> Medco manufactures pharmaceuticals and medical devices.  </P></p>
		</main>
</body></html>
            